Richard E. Helmer
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 5
- Hemoglobinopathies and Related Disorders 2
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
-
- Hematopoietic Stem Cell Transplantation 2
- Platelet Disorders and Treatments 2
- Acute Myeloid Leukemia Research 1
- Hemophilia Treatment and Research 1
- Co-authors
- Richard D. Leavitt (1 shared paper)Stephen D. Nimer (1 shared paper)Carlos de Castro Lozano (1 shared paper)Maher Albitar (1 shared paper)Hussain I. Saba (1 shared paper)Jean‐Pierre J. Issa (1 shared paper)Virginia M. Klimek (1 shared paper)Farhad Ravandi (1 shared paper)
- Journals
- Lung (1 paper)Cancer (1 paper)Acta Haematologica (1 paper)Cellular and Molecular Life Sciences (1 paper)The American Journal of Medicine (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Richard E. Helmer
8 papers receiving 1.2k citations
Richard E. Helmer's Hit Papers
Peers
Comparison fields: 5 of 67
- Hematology 829
- Genetics 215
- Molecular Biology 624
- Emergency Medicine 42
- Public Health, Environmental and Occupational Health 135
Countries citing papers authored by Richard E. Helmer
This map shows the geographic impact of Richard E. Helmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Helmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Helmer more than expected).
Fields of papers citing papers by Richard E. Helmer
This network shows the impact of papers produced by Richard E. Helmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Helmer. The network helps show where Richard E. Helmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard E. Helmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Decitabine improves patient outcomes in myelodysplastic syndromes Hit paper breakdown → | 2006 | 1151 |
| 2 | 2000 | 51 | |
| 3 | Bone-marrow imaging with indium-111 chloride in aplastic anemia and myelofibrosis: concise communication. | 1982 | 20 |
| 4 | 1980 | 18 | |
| 5 | Abnormal marrow fibroblasts in aplastic anemia. | 1984 | 13 |
| 6 | 2015 | 6 | |
| 7 | 1979 | 2 | |
| 8 | The effect of dexamethasone on the growth of bone marrow fibroblasts in aplastic anemia. | 1984 | 1 |
| 9 | 2009 | 0 |
About Richard E. Helmer
Richard E. Helmer is a scholar working on Genetics, Hematology, Surgery, Emergency Medicine and Orthopedics and Sports Medicine, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bone and Joint Diseases (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Platelet Disorders and Treatments (2 papers), Hematological disorders and diagnostics (2 papers), Acute Myeloid Leukemia Research (1 paper), Hemophilia Treatment and Research (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Hematology (829 citations), Genetics (215 citations), Molecular Biology (624 citations), Emergency Medicine (42 citations) and Public Health, Environmental and Occupational Health (135 citations). Richard E. Helmer has collaborated with scholars based in United States and Australia. Frequent co-authors include Richard D. Leavitt, Stephen D. Nimer, Carlos de Castro Lozano, Maher Albitar, Hussain I. Saba, Jean‐Pierre J. Issa, Virginia M. Klimek, Farhad Ravandi, Azra Raza and John F. DiPersio. Their work appears in journals such as Lung, Cancer, Acta Haematologica, Cellular and Molecular Life Sciences and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.